Skip to content

Eleonora Comi

  • Researcher, Post Doc
  • Rottapharm Biotech Srl
  • 1h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2CitationsNumber of citations received by Eleonora's publications. Updated daily.

Co-authors (30)

  • chiara sabatini
  • emanuele sala
  • Francesca Gualtieri

Publications (3)

  • Pharmacological characterisation of CR6086, a potent prostaglandin E<inf>2</inf>receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug

    • Caselli G
    • Bonazzi A
    • Lanza M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis

    • Comi E
    • Lanza M
    • Ferrari F
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation

    • Caprioli G
    • Mammoli V
    • Ricciutelli M
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Researcher, Post Doc

Rottapharm Biotech Srl

January 2016 - Present

Education

PhD in Neuroscience

Univesity of Milan Bicocca

February 2014 - April 2017(3 years)

Master's Degree in Biology

University of Milan-Bicocca Department of Biotechnology and Biosciences

November 2011 - January 2014(2 years)

Bachelor's Degree in Biological Sciences

University of Milan-Bicocca Department of Biotechnology and Biosciences

October 2008 - October 2011(3 years)